This research service provides revenue forecasts for CROs globally, by phase and market type, R&D spending trends of pharmaceutical and biotechnology companies and pipeline drugs and clinical trial trends by phase and region.

For the purpose of this research service, the U.S. CRO markets include revenues derived from the preclinical and clinical services offered by CROs to pharmaceutical and biotechnology sponsors in conducting clinical trials. The markets are approached from a service provider's perspective.